产品名称
Anti-Caldesmon Antibody, smooth muscle, clone N5/22, clone N5/22, Chemicon®, from mouse
biological source
mouse
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
N5/22, monoclonal
species reactivity
rabbit, bovine, human, pig
manufacturer/tradename
Chemicon®
technique(s)
immunocytochemistry: suitable
immunohistochemistry: suitable (paraffin)
immunoprecipitation (IP): suitable
western blot: suitable
isotype
IgG1
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Quality Level
Gene Information
human ... CALD1(800)
Analysis Note
Control
POSITIVE CONTROL:
Smooth muscle (e.g. aterial tunica media). Negative control: any nonmuscle tissue (e.g. arterial tunica adentitial).
POSITIVE CONTROL:
Smooth muscle (e.g. aterial tunica media). Negative control: any nonmuscle tissue (e.g. arterial tunica adentitial).
Application
Detect Caldesmon using this Anti-Caldesmon Antibody, smooth muscle, clone N5/22 validated for use in IP, WB, IC, IH(P).
Research Category
Metabolism
Metabolism
Research Sub Category
Muscle Physiology
Muscle Physiology
Western blot. Suggested blocking buffer is TBS-Tween with 2% BSA. Suggested dilution buffer is TBS-Tween with 0.05% sodium azide. Preferred gel percentage is 7% and/or 4-20% (or similar) gradient gel.
Immunohistochemistry on frozen and paraffin embedded tissue sections. Suggested fixation for frozen tissue sections is acetone fix for 6 minutes at room temperature. For formalin fixed paraffin embedded tissue sections: microwave in 0.01M citrate buffer (pH 6.0) for 8-10 minutes (note that all microwaves differ and adjustments may need to be made) follow with enzyme digestion (0.01% pronase for 10 mintues). Suggested blocking agent is fetal bovine serum. The antibody has also been used successfully on methyl-Carnoy fixed tissue.
Immunocytochemistry
Immunoprecipitation. Suggested extraction buffer is 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholic acid-NaCl and 0.5 mM PMSF. Final reaction volume is 1 mL and suggested capture agent is agarose conjugated anti-mouse IgG.
Optimal working dilutions must be determined by the end user.
Immunohistochemistry on frozen and paraffin embedded tissue sections. Suggested fixation for frozen tissue sections is acetone fix for 6 minutes at room temperature. For formalin fixed paraffin embedded tissue sections: microwave in 0.01M citrate buffer (pH 6.0) for 8-10 minutes (note that all microwaves differ and adjustments may need to be made) follow with enzyme digestion (0.01% pronase for 10 mintues). Suggested blocking agent is fetal bovine serum. The antibody has also been used successfully on methyl-Carnoy fixed tissue.
Immunocytochemistry
Immunoprecipitation. Suggested extraction buffer is 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholic acid-NaCl and 0.5 mM PMSF. Final reaction volume is 1 mL and suggested capture agent is agarose conjugated anti-mouse IgG.
Optimal working dilutions must be determined by the end user.
Biochem/physiol Actions
Caldesmon, smooth muscle. By Western blot the antibody recognizes a protein of 150-kDa.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
General description
Caldesmon is a protein component of the thin filaments of smooth muscle myofibrils. It
is also localized in the stress fibers of fibroblasts. Caldesmon was identified as a
Ca2+/Calmodulin-binding protein with molecular weight of 120-150kDa (H-Caldesmon)
and 70-80kDa (L-Caldesmon). H-Caldesmon is the primary isoform in smooth muscle
while L-Caldesmon is most abundant in non-muscle cells. Caldesmon is capable of
binding two calmodulin molecules, one at either end of the protein. Additionally,
Caldesmon is an actin, myosin, and tropomyosin-binding protein. Human L-Caldesmon
is a protein of 538 amino acids with mobility of 80kDa. In vitro, L-Caldesmon inhibits
the actomyosin ATPase in an F-Actin-dependent manner. L-Caldesmon may play an
important function in motile processes such as secretion and organelle movement.
is also localized in the stress fibers of fibroblasts. Caldesmon was identified as a
Ca2+/Calmodulin-binding protein with molecular weight of 120-150kDa (H-Caldesmon)
and 70-80kDa (L-Caldesmon). H-Caldesmon is the primary isoform in smooth muscle
while L-Caldesmon is most abundant in non-muscle cells. Caldesmon is capable of
binding two calmodulin molecules, one at either end of the protein. Additionally,
Caldesmon is an actin, myosin, and tropomyosin-binding protein. Human L-Caldesmon
is a protein of 538 amino acids with mobility of 80kDa. In vitro, L-Caldesmon inhibits
the actomyosin ATPase in an F-Actin-dependent manner. L-Caldesmon may play an
important function in motile processes such as secretion and organelle movement.
Immunogen
Crude smooth muscle extract from normal human adult uterus.
Epitope: smooth muscle
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Replaces: 04-590
Physical form
Format: Purified
Liquid in 0.02M Phosphate buffer with 0.25M NaCl and 0.1% sodium azide.
Preparation Note
Maintain at 2-8°C in undiluted aliquots up to 6 months after date of receipt
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品?
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Jonathan Paul et al.
PloS one, 6(6), e21542-e21542 (2011-07-09)
Human myometrium develops phasic contractions during labor. Phosphorylation of caldesmon (h-CaD) and extracellular signal-regulated kinase 1/2 (ERK 1/2) has been implicated in development of these contractions, however the phospho-regulation of these proteins is yet to be examined during periods of
Alvaro Yogi et al.
Biomedicines, 9(7) (2021-08-07)
Synthetic grafts have been developed for vascular bypass surgery, however, the risks of thrombosis and neointimal hyperplasia still limit their use. Tissue engineering with the use of adipose-derived stem cells (ASCs) has shown promise in addressing these limitations. Here we
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持